- €642.43m
- €2.36bn
- €3.96bn
- 81
- 95
- 56
- 93
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,201 | 4,512 | 4,468 | 4,352 | 3,964 |
Cost of Revenue | |||||
Gross Profit | 1,372 | 1,376 | 1,392 | 1,281 | 1,167 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,860 | 4,240 | 3,948 | 3,991 | 3,728 |
Operating Profit | 341 | 272 | 520 | 361 | 237 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 266 | 189 | 437 | 300 | 137 |
Provision for Income Taxes | |||||
Net Income After Taxes | 169 | 121 | 338 | 212 | 85.8 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 161 | 113 | 325 | 188 | 19.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 161 | 113 | 325 | 188 | 21.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.52 | 1.76 | 3.79 | 2.95 | 0.33 |
Dividends per Share |